Clinical trial
Benfotiamine in Alzheimer's Disease: A Pilot Study
NCT02292238 is registered in ClinicalTrials.gov with Burke Medical Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benfotiamine in Alzheimer's Disease: A Pilot Study
- Lead sponsor
- Burke Medical Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 15, 2015
- Completion date
- September 8, 2020
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease